iconEarnings Announcement Before Market Open

Fulcrum Therapeutics Inc FULC:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 8:12 AM EDT
8.51quote price arrow up+1.04 (+13.92%)
Volume
162,508
Close
7.47quote price arrow down-0.03 (-0.40%)
Volume
303,128
52 week range
2.65 - 13.70
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.47
  • 52 Week High13.70
  • 52 Week High Date03/06/24
  • 52 Week Low2.65
  • 52 Week Low Date06/01/23

Key Stats

  • Market Cap464.288M
  • Shares Out62.15M
  • 10 Day Average Volume0.29M
  • Dividend-
  • Dividend Yield-
  • Beta2.33
  • YTD % Change10.67

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.47
  • 52 Week High13.70
  • 52 Week High Date03/06/24
  • 52 Week Low2.65
  • 52 Week Low Date06/01/23
  • Market Cap464.288M
  • Shares Out62.15M
  • 10 Day Average Volume0.29M
  • Dividend-
  • Dividend Yield-
  • Beta2.33
  • YTD % Change10.67

RATIOS/PROFITABILITY

  • EPS (TTM)-1.59
  • P/E (TTM)-4.70
  • Fwd P/E (NTM)-4.19
  • EBITDA (TTM)-108.425M
  • ROE (TTM)-44.84%
  • Revenue (TTM)2.805M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-3,470.05%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Fulcrum Therapeutics Inc

 

Profile

MORE
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. The Company’s clinical product candidate, losmapimod, is developed for the potential treatment of facioscapulohumeral muscular dystrophy (FSHD). Its other clinical product candidate is FTX-6058, which is developed for the treatment of certain hemoglobinopathies, including...
Kate Haviland
Independent Chairman of the Board
Alex Sapir
President, Chief Executive Officer, Director
Alan Musso CPA
Chief Financial Officer, Treasurer
Address
26 Landsdowne Street
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
THRD
Third Harmonic Bio Inc
11.90-0.40-3.25%
OCS
Oculis Holding AG
12.07+0.10+0.88%
LRMR
Larimar Therapeutics Inc
7.12-0.74-9.41%
STTK
Shattuck Labs Inc
10.42-0.24-2.25%
PEPG
PepGen Inc
14.01+0.67+5.02%